PE20020394A1 - Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2 - Google Patents
Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2Info
- Publication number
- PE20020394A1 PE20020394A1 PE2001000819A PE2001000819A PE20020394A1 PE 20020394 A1 PE20020394 A1 PE 20020394A1 PE 2001000819 A PE2001000819 A PE 2001000819A PE 2001000819 A PE2001000819 A PE 2001000819A PE 20020394 A1 PE20020394 A1 PE 20020394A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- alcoxy
- alkenyl
- hadh2
- erab
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
SE REFIERE A COMPUESTOS DE PIRAZOL DE FORMULA I DONDE X ES O, S; Y ES N, CH; R6 ES H, OH; R ES -(R1)(R7)C-C(=O)-NR2R3; C(R1)(R7)-C(=O)R5; C(R1)(R7)-C(=O)OR4; R1 ES H, ALQUILO, ALQUENILO, ALQUINILO, ALCOXI, ALILOXI, ARILO, ENTRE OTROS; R2 Y R3 SON H, ALQUILO, ALQUENILO, ALCOXI, ARILO, HETEROARILO, ENTRE OTROS; R4 ES H, ALQUILO, ALQUENILO, CICLOALQUILO, HETEROCICLOALQUILO; R5 ES H, ALQUILO, ALQUENILO, ALQUINILO, CICLOALQUILO, ENTRE OTROS; R7 ES H, ALQUILO C1-C3, HIDROXI, ALCOXI C1-C3. TAMBIEN SE REFIERE AL USO EN COMBINACION CON ESTROGENO, NSAIDS, RISPERIDONA, TIOBENZODIAZEPINA, AMPAQUINA, [N-(2,6-DIMETILFENIL)-2-(2-OXO-1-PIRROLIDINIL)ACETAMIDA, UN INHIBIDOR DE COLINESTERASA, DONEPEZIL, RIVASTIGMINA, GALANTAMINA, METRIFONATO. LOS COMPUESTOS SON INHIBIDORES DE LA PROTEINA AMILOIDE ß LIGADORA ASOCIADA CON EL RETICULO ENDOPLASMICO Y L-3-HIDROXIACIL-COA DESHIDROGENASA CLASE II ERAB/HADH2 QUE CATALIZA LA OXIDACION REVERSIBLE DEL L-3-HIDROXIACIL-COA Y PUEDE SER UTIL PARA EL TRATAMIENTO DE ENFERMEDADES NEURODEGENERATIVAS Y NEOPLASIAS MALIGNAS COMO CANCER DE MAMA O ENDOMETRIO
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22612300P | 2000-08-18 | 2000-08-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20020394A1 true PE20020394A1 (es) | 2002-06-21 |
Family
ID=22847647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2001000819A PE20020394A1 (es) | 2000-08-18 | 2001-08-16 | Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2 |
Country Status (14)
Country | Link |
---|---|
US (2) | US6964957B2 (es) |
EP (2) | EP1311511A1 (es) |
JP (2) | JP2004506737A (es) |
AR (1) | AR035486A1 (es) |
AU (1) | AU2001296854A1 (es) |
BR (1) | BR0113461A (es) |
CA (2) | CA2415182A1 (es) |
GT (1) | GT200100169A (es) |
HK (1) | HK1046288A1 (es) |
MX (1) | MXPA03001455A (es) |
PA (1) | PA8525801A1 (es) |
PE (1) | PE20020394A1 (es) |
UY (1) | UY26895A1 (es) |
WO (1) | WO2002016365A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10221052A1 (de) * | 2002-05-10 | 2003-12-04 | Transmit Technologietransfer | Wirkstoffe zu Therapie, Diagnostik und Prophylaxe von Erkrankungen, bei denen abnorme Proteinstrukturen auftreten |
EP1627323A4 (en) * | 2003-05-06 | 2008-04-09 | New Century Pharmaceuticals | ALBUMIN FIXATION SITES FOR EVALUATING DRUG INTERACTIONS OR THE DEVELOPMENT OF MEDICAMENTS BASED ON THEIR ALBUMIN BINDING PROPERTIES |
US20070043509A1 (en) * | 2003-11-03 | 2007-02-22 | Carter Daniel C | Albumin binding sites for evaluating drug interactions and methods of evaluating or designing drugs based on their albumin binding properties |
US20080274975A1 (en) * | 2004-04-12 | 2008-11-06 | The Trustees Of Columbia University In The City Of New Yourk | Methods and Compositions for Inhibiting Abad/Abeta Protein Interaction |
US9132135B2 (en) * | 2004-09-24 | 2015-09-15 | University Of Maryland, Baltimore | Method of treating organophosphorous poisoning |
PL1791904T3 (pl) * | 2004-09-24 | 2015-02-27 | Univ Maryland | Sposób leczenia zatrucia związkami fosforoorganicznymi |
WO2010118367A2 (en) * | 2009-04-10 | 2010-10-14 | Progenics Pharmaceuticals, Inc. | Antiviral pyrimidines |
TWI698436B (zh) * | 2014-12-30 | 2020-07-11 | 美商佛瑪治療公司 | 作為泛素特異性蛋白酶7抑制劑之吡咯并及吡唑并嘧啶 |
MA41291A (fr) | 2014-12-30 | 2017-11-07 | Forma Therapeutics Inc | Dérivés de la pyrrolotriazinone et de l'imidazotriazinone en tant qu'inhibiteurs de la protéase spécifique de l'ubiquitine n° 7 (usp7) pour le traitement d'un cancer |
EP3253765A1 (en) | 2015-02-05 | 2017-12-13 | Forma Therapeutics, Inc. | Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors |
WO2016126935A1 (en) | 2015-02-05 | 2016-08-11 | Forma Therapeutics, Inc. | Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors |
US9840491B2 (en) | 2015-02-05 | 2017-12-12 | Forma Therapeutics, Inc. | Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors |
WO2023146880A1 (en) * | 2022-01-25 | 2023-08-03 | Board Of Regents Of The University Of Nebraska | Functionalized allopurinol derivatives for treatment of alzheimer's disease |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3165520A (en) | 1965-01-12 | Certificate of correction | ||
US4666908A (en) | 1985-04-05 | 1987-05-19 | Warner-Lambert Company | 5-Substituted pyrazolo[4,3-d]pyrimidine-7-ones and methods of use |
DE68908786T2 (de) | 1988-06-16 | 1994-03-17 | Smith Kline French Lab | Condensierte Pyrimidinderivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen. |
US5109119A (en) * | 1989-06-06 | 1992-04-28 | Schering Corporation | Crystalline r-h-gm-csf and method |
GB9013750D0 (en) | 1990-06-20 | 1990-08-08 | Pfizer Ltd | Therapeutic agents |
GB9114760D0 (en) | 1991-07-09 | 1991-08-28 | Pfizer Ltd | Therapeutic agents |
US5294612A (en) * | 1992-03-30 | 1994-03-15 | Sterling Winthrop Inc. | 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof |
US5322933A (en) * | 1992-05-07 | 1994-06-21 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Crystal structure of TGF-β-2 |
PH31122A (en) | 1993-03-31 | 1998-02-23 | Eisai Co Ltd | Nitrogen-containing fused-heterocycle compounds. |
US5294611A (en) | 1993-04-23 | 1994-03-15 | American Cyanamid Company | Angiotensin II receptor blocking 2,3,6 substituted quinazolinones |
GB9301192D0 (en) | 1993-06-09 | 1993-06-09 | Trott Francis W | Flower shaped mechanised table |
US5556778A (en) * | 1994-04-28 | 1996-09-17 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | Crystalline Inha Enzyme-NADH Complex |
ATE182332T1 (de) | 1994-06-16 | 1999-08-15 | Pfizer | Pyrazolo und pyrrolopyridine |
US5756466A (en) | 1994-06-17 | 1998-05-26 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1β converting enzyme |
GB9423910D0 (en) | 1994-11-26 | 1995-01-11 | Pfizer Ltd | Therapeutic agents |
US5656629A (en) | 1995-03-10 | 1997-08-12 | Sanofi Winthrop, Inc. | 6-substituted pyrazolo (3,4-d)pyrimidin-4-ones and compositions and methods of use thereof |
US6153652A (en) | 1996-11-22 | 2000-11-28 | Elan Pharmaceuticals, Inc. | N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
US6555651B2 (en) | 1997-10-09 | 2003-04-29 | The Trustees Of Columbia University In The City Of New York | Ligand binding site of rage and uses thereof |
US6268479B1 (en) | 1997-03-12 | 2001-07-31 | The Trustees Of Columbia University In The City Of New York | Intracellular amyloid-beta peptide binding (ERAB) polypeptide |
EP1019501A1 (en) | 1997-03-14 | 2000-07-19 | Otsuka Pharmaceutical Co., Ltd. | Novel pyrimidine derivative |
WO1998049166A1 (en) | 1997-04-25 | 1998-11-05 | Pfizer Limited | PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
US6020162A (en) * | 1997-06-13 | 2000-02-01 | The Rockefeller University | Crystal of a protein-ligand complex containing an N-terminal truncated eIF4E, and methods of use thereof |
US5872011A (en) * | 1997-06-13 | 1999-02-16 | The Rockefeller University | Crystal of a protein-ligand complex containing an N-terminal truncated eIF4E, and methods of use thereof |
ATE355841T1 (de) | 1997-12-13 | 2007-03-15 | Bristol Myers Squibb Co | Verwendung von pyrazolo ( 3,4-b) pyridin als cyclin-abhängige kinase hemmer |
US6194410B1 (en) | 1998-03-11 | 2001-02-27 | Hoffman-La Roche Inc. | Pyrazolopyrimidine and pyrazolines and process for preparation thereof |
GB9822238D0 (en) | 1998-10-12 | 1998-12-09 | Pfizer Ltd | Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof |
AUPP672198A0 (en) * | 1998-10-23 | 1998-11-19 | Fujisawa Pharmaceutical Co., Ltd. | Pyrazolopyridine compound and pharmaceutical use thereof |
DZ3262A1 (fr) | 1999-06-10 | 2000-12-12 | Warner Lambert Co | Procede d'inhibition d'agregation de proteines amyloides et d'imagerie de depots amyloides au moyen de derives d'isoindoline |
TR200103562T2 (tr) | 1999-06-10 | 2002-04-22 | Warner-Lambert Company | Amiloid proteini toplanmasını önleme ve amiloid birikintilerini görüntüleme yönteminde kullanım için rodanin türevleri |
AU5455400A (en) | 1999-06-10 | 2001-01-02 | Warner-Lambert Company | Rhodanine derivatives and their use in inhibiting and imaging amyloids |
WO2001012598A2 (en) | 1999-08-13 | 2001-02-22 | The Trustees Of Columbia University In The City Of New York | METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
-
2001
- 2001-08-16 PE PE2001000819A patent/PE20020394A1/es not_active Application Discontinuation
- 2001-08-17 US US09/931,166 patent/US6964957B2/en not_active Expired - Fee Related
- 2001-08-17 JP JP2002521466A patent/JP2004506737A/ja not_active Withdrawn
- 2001-08-17 WO PCT/US2001/041795 patent/WO2002016365A1/en not_active Application Discontinuation
- 2001-08-17 UY UY26895A patent/UY26895A1/es not_active Application Discontinuation
- 2001-08-17 CA CA002415182A patent/CA2415182A1/en not_active Abandoned
- 2001-08-17 CA CA002354653A patent/CA2354653A1/en not_active Abandoned
- 2001-08-17 BR BR0113461-2A patent/BR0113461A/pt not_active IP Right Cessation
- 2001-08-17 PA PA20018525801A patent/PA8525801A1/es unknown
- 2001-08-17 MX MXPA03001455A patent/MXPA03001455A/es unknown
- 2001-08-17 US US09/931,186 patent/US20020132319A1/en not_active Abandoned
- 2001-08-17 AR ARP010103959A patent/AR035486A1/es not_active Application Discontinuation
- 2001-08-17 EP EP01977762A patent/EP1311511A1/en not_active Withdrawn
- 2001-08-17 AU AU2001296854A patent/AU2001296854A1/en not_active Abandoned
- 2001-08-17 GT GT200100169A patent/GT200100169A/es unknown
- 2001-08-20 EP EP01307075A patent/EP1223176A3/en not_active Withdrawn
- 2001-08-20 JP JP2001249448A patent/JP2002360269A/ja active Pending
-
2002
- 2002-10-15 HK HK02107461.3A patent/HK1046288A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2002016365A1 (en) | 2002-02-28 |
PA8525801A1 (es) | 2002-08-29 |
CA2354653A1 (en) | 2002-02-18 |
CA2415182A1 (en) | 2002-02-28 |
HK1046288A1 (zh) | 2003-01-03 |
MXPA03001455A (es) | 2004-05-04 |
EP1311511A1 (en) | 2003-05-21 |
EP1223176A2 (en) | 2002-07-17 |
AU2001296854A1 (en) | 2002-03-04 |
UY26895A1 (es) | 2002-04-26 |
BR0113461A (pt) | 2003-07-01 |
US20020065292A1 (en) | 2002-05-30 |
JP2004506737A (ja) | 2004-03-04 |
GT200100169A (es) | 2002-05-16 |
US6964957B2 (en) | 2005-11-15 |
AR035486A1 (es) | 2004-06-02 |
EP1223176A3 (en) | 2002-10-23 |
US20020132319A1 (en) | 2002-09-19 |
JP2002360269A (ja) | 2002-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20020394A1 (es) | Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2 | |
PE20230238A1 (es) | Inhibidores de kras g12c | |
PE20221253A1 (es) | Inhibidores de pequenas moleculas de mutante g12c de kras | |
ECSP045229A (es) | Piridinonas sustituidas como moduladores de la p38 map quinasa | |
AR047076A1 (es) | Compuestos de pirrolotriazina como inhibidores de tirosina quinasas, composiciones farmaceuticas | |
PA8490601A1 (es) | Derivados quinolin-2-ona sustituidos con heteroarilo utiles como agentes anticancerigenos. | |
PE20040165A1 (es) | Uso de analogos del benzimidazol en el tratamiento de la proliferacion celular | |
AR022230A1 (es) | Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para preparar dicha composicion | |
PE20001093A1 (es) | 3-amino-4-aril-maleimidas como inhibidores de gsk-3 | |
AR011116A1 (es) | Compuesto derivado de n-hidroxi-beta-sulfonil propionamida y composicion farmaceutica que lo contiene | |
SV1998000008A (es) | Inhibisores de sulfamida-metaloproteasa. ref. ran 4070\114 | |
PE99999A1 (es) | 4,5-diarilimidazoles 2-sustituidos | |
AR029216A1 (es) | Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento | |
NZ503788A (en) | 4-aminothiazole derivatives and their use as inhibitors of cyclin-dependent kinases | |
SV1999000141A (es) | Derivados de quinolin-2-ona alquinilsustituidos utiles como agentes anticancerosos ref. pc10411abcz/bb | |
AR023727A1 (es) | Compuestos empleados en el tratamiento de padecimientos inflamatorios | |
PE20090042A1 (es) | Analogos de ciclopamina | |
TR200200099T2 (tr) | Th2 farklılaşma inhibitörleri | |
ATE232520T1 (de) | Imidazolidin-4-on derivate verwendbar als antikrebsmittel | |
AR040928A1 (es) | Compuestos de acidos sulfona-hidroxamicos aromaticos, composiciones farmaceuticas y su uso en la preparacion de medicamentos utiles como inhibidores de proteasas | |
CO4950553A1 (es) | Compuestos de 7-tetrahidroisoquinolinas y procedimiento para su preparacion | |
SV2006002089A (es) | Nuevos imidazoles ref. docket 18699 (pc26195a) | |
AR040274A1 (es) | Derivados de 1-[(indol-3-il)carbonil]piperazina como agonistas de canabinoides en el tratamiento del dolor y composiciones farmaceuticas | |
AR055367A1 (es) | Piperazinas biciclicas como antagonistas de receptores de glutamato metabotropicos | |
UY27770A1 (es) | Imidazolinilmetil aralquilsulfonamidas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |